Nuveen Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-670
| Closed | -$8.96K | – | 3339 |
|
|
2024
Q2 | $8.96K | Sell |
670
-107,207
| -99% | -$1.43M | ﹤0.01% | 3327 |
|
|
2024
Q1 | $5.01M | Buy |
107,877
+89
| +0.1% | +$4.13K | ﹤0.01% | 1995 |
|
|
2023
Q4 | $7.29M | Buy |
107,788
+6,648
| +7% | +$449K | ﹤0.01% | 1772 |
|
|
2023
Q3 | $7.32M | Buy |
101,140
+11,398
| +13% | +$825K | ﹤0.01% | 1667 |
|
|
2023
Q2 | $6.68M | Buy |
89,742
+16,933
| +23% | +$1.26M | ﹤0.01% | 1750 |
|
|
2023
Q1 | $3.87M | Buy |
72,809
+18,221
| +33% | +$969K | ﹤0.01% | 2032 |
|
|
2022
Q4 | $3.69M | Sell |
54,588
-16,297
| -23% | -$1.1M | ﹤0.01% | 2084 |
|
|
2022
Q3 | $8.85M | Buy |
70,885
+30,979
| +78% | +$3.87M | ﹤0.01% | 1555 |
|
|
2022
Q2 | $3.8M | Buy |
+39,906
| New | +$3.8M | ﹤0.01% | 2130 |
|